This survey was conducted to assess the attitudes of medical practitioners in the European Union regarding their national spontaneous reporting scheme, to identify reasons for under-reporting and to determine what steps might be effective in increasing reporting rates.
National spontaneous reporting schemes rely on health care professionals reporting individual cases of suspected ADRs to a central or regional agency.
National schemes, however, vary considerably and reporting rates and patterns differ between member states.
Accumulating evidence suggests that doctors attitudes to national ADR reporting schemes are significant determinants of reporting rates.
A self-administered questionnaire and letter of invitation was sent to a random sample of approximately 1% of medical practitioners in each of nine EU member states (Denmark, France, Ireland, Italy, the Netherlands, Portugal, Spain, Sweden and the UK).
One month later, a reminder letter and a second copy of the questionnaire was sent to the non-responders (except Denmark and Italy).
Response rates, and the percentage of responders who stated that they had reported previously an ADR, varied substantially between countries.
Issues that appeared to discourage reporting included lack of availability of report forms ; the address or telephone number of the reporting agency ; lack of information on how to report ; and not having enough time to report. (...)
Mots-clés Pascal : Union européenne, Pharmacovigilance, Médecin, Toxicité, Médicament, Attitude, Pratique professionnelle, Personnel sanitaire
Mots-clés Pascal anglais : European Union, Pharmacovigilance, Physician, Toxicity, Drug, Attitude, Professional practice, Health staff
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 97-0482605
Code Inist : 002B02A06. Création : 03/02/1998.